Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Jul 6;25(9):1341–1347. doi: 10.1158/1055-9965.EPI-16-0176

Table 1.

Characteristics of study participants.

Variable Lung Cancer Cases (n=341) Controls (n=752) p-value
Gender (n, %)
 Male 158 (46.3) 342 (45.5) 0.793
 Female 183 (53.7) 410 (54.5)
Race (n, %)
 White 190 (55.7) 388 (51.6) 0.206
 Black 151 (44.3) 364 (48.4)
Age (mean, SD) 63.7 (9.8) 61.5 (9.3) 0.001
Family history of lung cancer (n, %)
 No 259 (76.2) 640 (85.1) <0.001
 Yes 81 (23.8) 112 (14.9)
Smoking status (n, %)
 Never1 24 (7.0) 7 (0.9) <0.001
 Ever 317 (93.0) 745 (99.1)
Pack years (smokers only) (mean, SD) 43.6 (30.4) 36.2 (25.5) <0.001
Histology
 Adenocarcinoma 180 (53.6)
 Squamous cell 90 (26.8)
 Other NSCLC2 15 (4.5) --
 Small Cell 30 (8.9)
 Other 21 (6.2)
Stage3
 I 84 (24.9) --
 II 50 (14.8) -- --
 III 90 (26.6) --
 IV 114 (33.7) --
1

Never smokers are defined as having smoked fewer than 100 cigarettes in their lifetime.

2

Other non-small cell lung cancer (NSCLC) includes types such as adenosquamous and large cell.

3

Stage is defined according to American Joint Committee on Cancer guidelines.